Related Experiment Video

Updated: May 29, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Insulin therapy in children and adolescents with diabetes

Assimina Galli-Tsinopoulou1

  • 14th Department of Pediatrics, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece. gallitsin@gmail.com

Diabetes Research and Clinical Practice
|August 26, 2011
PubMed

Insights

Type 1 diabetes is a growing global health issue for children and adolescents, requiring lifelong insulin therapy. Continuous subcutaneous insulin infusion systems (pumps) offer improved metabolic control and reduced complications in pediatric patients.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 1 diabetes (T1D) is a significant and increasing global health concern in pediatric populations.
  • Children and adolescents with T1D rely on exogenous insulin for survival.
  • Current insulin therapies include traditional forms and insulin analogs.

Purpose of the Study:

  • To review current insulin treatment modalities for pediatric patients with Type 1 diabetes.
  • To highlight advancements in insulin administration, focusing on continuous subcutaneous insulin infusion systems.
  • To discuss the impact of these advancements on metabolic control and complication reduction.

Main Methods:

  • Literature review of current insulin therapies and administration methods for Type 1 diabetes in children and adolescents.
  • Analysis of data regarding the efficacy of continuous subcutaneous insulin infusion systems (pumps) in pediatric T1D management.
  • Synthesis of information on metabolic outcomes and complication rates associated with different insulin delivery methods.

Main Results:

  • Insulin therapy, including analogs, is standard for pediatric T1D.
  • Continuous subcutaneous insulin infusion systems (pumps) represent a significant advancement in insulin delivery.
  • These systems aim to improve metabolic control and decrease diabetic complications in young patients.

Conclusions:

  • Type 1 diabetes management in children and adolescents requires effective insulin strategies.
  • Continuous subcutaneous insulin infusion systems offer a promising approach to enhance treatment outcomes.
  • Further research and adoption of advanced insulin delivery systems are crucial for improving the lives of pediatric T1D patients.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...